In-Gyu Lee
Directeur/Bestuurslid bij NOVMETAPHARMA CO., LTD.
Profiel
In-Gyu Lee is currently a Director at NovMetaPharma Co., Ltd.
and NovMetaHealth Co. Ltd.
He is also a Professor at Kyungpook National University, a position he has held since 2005.
He received his undergraduate, graduate, and doctorate degrees from Kyungpook National University.
Actieve functies van In-Gyu Lee
| Bedrijven | Functie | Begin |
|---|---|---|
| NOVMETAPHARMA CO., LTD. | Directeur/Bestuurslid | 13-12-2017 |
| Kyungpook National University | Corporate Officer/Principal | 01-04-2005 |
NovMetaHealth Co. Ltd.
 NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Directeur/Bestuurslid | - |
Opleiding van In-Gyu Lee
| Kyungpook National University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NOVMETAPHARMA CO., LTD. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
NovMetaHealth Co. Ltd.
NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Health Technology |
